Document is current
Any future updates will be listed below
-
Authors
Jørstad, Øystein Kalsnes https://orcid.org/0000-0003-1259-0653
Foss, Stian
Gjølberg, Torleif Tollefsrud
Mester, Simone
Nyquist-Andersen, Mari
Sivertsen, Magne Sand
Fossum, Dag
Gleditsch, Espen
Moe, Morten Carstens
Andersen, Jan Terje
-
Funding
Funding for this research was provided by:
University of Oslo
- License Information
-
More Information
Article History
Received: 26 September 2023
Accepted: 26 October 2023
First Online: 7 November 2023
Declarations
:
: Not applicable.
: ØKJ has participated in Allergan, Bayer, and Roche advisory boards, has received lecture fees from Allergan and Bayer, and has a collaborative agreement with SJJ Solutions. TTG is co-founder, board member, and Chief Scientific Officer of Authera and board member in Authera Holding. SM is co-founder, board member, and Chief Executive Officer of Authera and board member and Chief Executive Officer in Authera Holding. MSS has a collaborative agreement with SJJ Solutions. MCM has participated in Allergan, Apellis, Bayer, Roche, and Novartis advisory boards, has received lecture fees from Bayer and Roche, and has a collaborative agreement with SJJ Solutions. JTA is co-founder and Chairman of the Board in Authera, co-founder and Chairman of the Board in Authera Holding, and has a collaborative agreement with SJJ Solutions. SF, MNA, DF, and EG have nothing to disclose.
